Intracranial Stent Graft

Reshaping Health Professional Training Intracranial Stent Graft


The cooperation with some healthcare professional on researches aimed to jointly develop intracranial stent graft and realize the commercialization.


The cerebrovascular diseases are characterized by high treatment risk and high fatality rate. With the development of interventional therapy and surgery, it is possible to have timely and effective treatment of most cerebrovascular diseases. However, it is still difficult for a number of patients suffering cerebrovascular diseases to obtain satisfactory treatment because of the particularity of their lesions and the restrictions of therapeutic materials. In 1996, a medical expert put forward the initial concept of treating patients suffering internal carotid artery defect with stent grafts. But it was difficult to realize the concept given that the challenges arising from the narrow and tortuous cerebrovascular lumens were beyond the domestic scientific and technological capacities at that time. Though the development of this new type of cerebrovascular stent graft has its special use, its application is limited and the market is small. Few companies in the world were willing to develop such products because of the high cost of research and development, long period and delicate manufacturing process. In 2004, MicroPort® officially organized a team to cooperate with the healthcare professional to develop the Cerebrovascular Stent Graft.


  • In 2004, the pre-development studies of intracranial stent graft was launched.
  • In January 2005, the research and development of the project was officially launched.
  • In February 2013, CFDA registration certificate was obtained.


  1. Successfully concluded scientific research cooperation;
  2. In November 2009, the Intracranial Stent Graft won the First Prize of Shanghai Science and Technology Progress Award.
  3. In February 2012, the Intracranial Stent Graft won the First Prize of Ministry of Education of Science and Technology Progress Award.
  4. In December 2013, the Intracranial Stent Graft was named as a New Patented Product of Shanghai Municipality.
  5. In December 2014, the Intracranial Stent Graft won the Second Prize of National Science and Technology Progress Award.
  6. A total of nine patent applications have been filed and 54 papers have been published.
  7. The Intracranial Stent Graft was successfully commercialization and is used in 500 domestic hospitals with more than 2,000 implantations.
  8. As of April 2019, the Intracranial Stent Graft is the only cerebrovascular stent graft in the world.